Disease/Infection News

RSS

Chronic intake of marijuana protects critical immune tissue from damaging effects of HIV infection

New evidence that chronic intake of THC, the primary psychoactive ingredient in marijuana, can protect critical immune tissue in the gut from the damaging effects of HIV infection is reported in AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

19 Feb 2014

Taste receptors act as first line sentinels against infection in upper airway

The body uses mucus as a protective barrier to defend against pathogens, toxins, and allergens in the upper respiratory tract that can lead to such conditions as chronic sinusitis.

19 Feb 2014

Scientists propose improved method of screening salmonella vaccines in small animal studies

An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines or RASVs can be perfected, they hold the promise of safe, lost-cost, orally administered defenses against viral, bacterial, fungal and parasitic infections.

19 Feb 2014

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).

19 Feb 2014

New study explores the effect of food insecurity on treating HIV-infected pregnant women in Uganda

In Uganda the prescription of three antiretroviral (ARV) drugs, which aim to suppress the virus to prevent disease progression, have resulted in huge reductions in HIV mortality rates. However, disease is not the only scourge in Uganda, and a new study in The Journal of Clinical Pharmacology explores the impact food insecurity may have on treating pregnant women.

18 Feb 2014

New research may provide insight on how dengue virus gains entry into cells

Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash. In some people the disease progresses to a severe, often fatal, form known as dengue hemorrhagic fever.

18 Feb 2014

Upstream interventions may provide options to contain emerging pathogens at source

While many endemic infectious diseases of humans have been largely contained, new microbes continue to emerge to threaten human and animal health.

18 Feb 2014

New drug patent may help overcome problems associated with MDR-TB

A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria once again responsive to antibiotics.

18 Feb 2014

GENFIT receives FDA Fast Track designation for GFT505 development program in NASH

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces that the Food and Drug Administration has granted Fast Track designation to the GFT505 development program in NASH, with effect from February 14, 2014.

18 Feb 2014

New approach for delivering vaccines and for stimulating body's immune system to attack tumors

Many vaccines, including those for influenza, polio, and measles, consist of a killed or disabled version of a virus. However, for certain diseases, this type of vaccine is ineffective, or just too risky.

18 Feb 2014

More men contract chlamydia in Australia, finds new study

The largest Australian chlamydia study to date, led by the University of Melbourne, has found more men contract chlamydia than previously thought and most cases of infection are being missed.

17 Feb 2014

Study provides comprehensive analysis of the evolutionary relationships of influenza virus

A new study reconstructing the evolutionary tree of flu viruses challenges conventional wisdom and solves some of the mysteries surrounding flu outbreaks of historical significance.

17 Feb 2014

Water samples from the Upper Ganges River shed light on the spread of superbugs

The spread of antibiotic-resistance to one of the most pristine locations in Asia is linked to the annual human pilgrimages to the region, new research has shown.

17 Feb 2014

Research findings may help combat MRSA

A research team from Vanderbilt University Medical Center in Nashville, Tenn., is the first to decipher the 3-D structure of a protein that confers antibiotic resistance from one of the most worrisome disease agents: a strain of bacteria called methicillin-resistant Staphylococcus aureus (MRSA), which can cause skin and other infections. The Vanderbilt team's findings may be an important step in combatting the MRSA public health threat over the next 5 to 10 years.

17 Feb 2014

Researcher reveals the secrets of Francisella tularensis bacterium that causes tularemia

Tularemia, aka "rabbit fever," is endemic in the northeastern United States, and is considered to be a significant risk to biosecurity -- much like anthrax or smallpox -- because it has already been weaponized in various regions of the world.

17 Feb 2014

Study: Societal pressures about vaccination has direct effect on spread of pediatric infectious diseases

Our response to societal pressures about vaccination has a direct effect on the spread of pediatric infectious diseases in areas where inoculation is not mandatory, says new research published this week in Proceedings of the Royal Society B.

17 Feb 2014

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

16 Feb 2014

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.

14 Feb 2014

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the launch of the Rusch® DispoLED™ Single-Use Fiber Optic Laryngoscope Handle — a cost-neutral way to combat cross-contamination infection risk during intubation.

14 Feb 2014

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

Four-year results of the Zilver PTX Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease continue to demonstrate consistent, superior results when compared to bare metal stents (BMS) and percutaneous transluminal angioplasty (PTA) in terms of primary patency, restenosis reduction and revascularization rates.

From COOK MEDICAL INC. 14 Feb 2014

Disease/Infection News

Chronic intake of marijuana protects critical immune tissue from damaging effects of HIV infection

Taste receptors act as first line sentinels against infection in upper airway

Scientists propose improved method of screening salmonella vaccines in small animal studies

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

New study explores the effect of food insecurity on treating HIV-infected pregnant women in Uganda

New research may provide insight on how dengue virus gains entry into cells

Upstream interventions may provide options to contain emerging pathogens at source

New drug patent may help overcome problems associated with MDR-TB

GENFIT receives FDA Fast Track designation for GFT505 development program in NASH

New approach for delivering vaccines and for stimulating body's immune system to attack tumors

More men contract chlamydia in Australia, finds new study

Study provides comprehensive analysis of the evolutionary relationships of influenza virus

Water samples from the Upper Ganges River shed light on the spread of superbugs

Research findings may help combat MRSA

Researcher reveals the secrets of Francisella tularensis bacterium that causes tularemia

Study: Societal pressures about vaccination has direct effect on spread of pediatric infectious diseases

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News